Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Castle Biosciences Inc (CSTL)

Castle Biosciences Inc (CSTL)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
21.26 +0.21 (+1.00%) 04/16/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 21.26 unch (unch) 16:29 ET
Quote Overview for Wed, Apr 16th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
20.38
Day High
21.47
Open 20.80
Previous Close 21.05 21.05
Volume 501,700 501,700
Avg Vol 325,190 325,190
Stochastic %K 87.47% 87.47%
Weighted Alpha -6.15 -6.15
5-Day Change +1.15 (+5.72%) +1.15 (+5.72%)
52-Week Range 16.97 - 35.84 16.97 - 35.84
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 607,187
  • Shares Outstanding, K 28,845
  • Annual Sales, $ 332,070 K
  • Annual Income, $ 18,250 K
  • EBIT $ 20 M
  • EBITDA $ 29 M
  • 60-Month Beta 1.11
  • Price/Sales 1.73
  • Price/Cash Flow 20.22
  • Price/Book 1.22

Options Overview Details

View History
  • Implied Volatility 74.53% ( -0.02%)
  • Historical Volatility 51.79%
  • IV Percentile 53%
  • IV Rank 49.29%
  • IV High 134.09% on 07/15/24
  • IV Low 16.64% on 05/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 15
  • Volume Avg (30-Day) 7
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 498
  • Open Int (30-Day) 494

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.09
  • Growth Rate Est. (year over year) +11.11%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.49 +21.56%
on 04/07/25
Period Open: 19.29
21.47 -0.98%
on 04/16/25
+1.97 (+10.21%)
since 03/14/25
3-Month
17.49 +21.56%
on 04/07/25
Period Open: 25.09
28.90 -26.44%
on 02/03/25
-3.83 (-15.27%)
since 01/16/25
52-Week
16.97 +25.32%
on 07/05/24
Period Open: 18.94
35.84 -40.68%
on 11/05/24
+2.32 (+12.25%)
since 04/16/24

Most Recent Stories

More News
Castle Biosciences to Release First Quarter 2025 Financial Results and Host Conference Call on Monday, May 5, 2025

CSTL : 21.26 (+1.00%)
Castle Biosciences Strengthens Commitment to Esophageal Cancer Awareness Through Collaborative Partnerships

CSTL : 21.26 (+1.00%)
Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year

CSTL : 21.26 (+1.00%)
Publication of Data from Prospective, Multicenter Study Demonstrates Positive Survival Outcomes in Patients with Low-Risk Melanoma Who Avoided Sentinel Lymph Node Biopsy with Information from Castle Biosciences’ DecisionDx®-Melanoma Test

CSTL : 21.26 (+1.00%)
Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma

CSTL : 21.26 (+1.00%)
Castle Biosciences' DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups

CSTL : 21.26 (+1.00%)
CSTL Gears Up to Report Q4 Earnings: Here's What You Should Know

Castle Biosciences, Inc. CSTL is scheduled to report fourth-quarter and full-year 2024 results on Feb. 27, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is...

MIRM : 38.75 (+0.31%)
CSTL : 21.26 (+1.00%)
PCRX : 24.47 (-1.65%)
Axsome Shares Rise 19% in a Month: What's Driving the Rally?

Axsome Therapeutics’ AXSM shares have rallied 19.4% in the past month against the industry’s decrease of 0.2%, driven by investor enthusiasm about the company’s encouraging preliminary sales numbers...

JAZZ : 101.55 (-1.32%)
VYGR : 3.13 (-2.49%)
CSTL : 21.26 (+1.00%)
AXSM : 104.47 (+0.62%)
Is it a Good Idea to Invest in Beam Therapeutics Stock Now?

Beam Therapeutics BEAM is developing its lead pipeline candidate, BEAM-101, a base-editing therapy, in the phase I/II BEACON study for treating sickle cell disease (SCD), an inherited blood disorder.BEAM’s...

BEAM : 16.62 (-3.82%)
VYGR : 3.13 (-2.49%)
CSTL : 21.26 (+1.00%)
HRMY : 27.94 (-2.82%)
4 Top-Ranked Stocks With Solid Net Profit Margins to Buy Now

The primary purpose of a business is to generate profits that can be reinvested in expansion or utilized for rewarding shareholders. Net profit margin is an effective tool to measure the profits reaped...

OPFI : 8.35 (-1.65%)
CSTL : 21.26 (+1.00%)
GCT : 12.05 (-2.59%)
QFIN : 36.54 (-5.75%)

Business Summary

Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.

See More

Key Turning Points

3rd Resistance Point 22.78
2nd Resistance Point 22.13
1st Resistance Point 21.69
Last Price 21.26
1st Support Level 20.60
2nd Support Level 19.95
3rd Support Level 19.51

See More

52-Week High 35.84
Fibonacci 61.8% 28.63
Fibonacci 50% 26.40
Fibonacci 38.2% 24.18
Last Price 21.26
52-Week Low 16.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro